Deal Library / Pharma BD Deal Intelligence

Pharma Deals of 2005

The Pharma Closeout tracks 36 deals, $105.4B in disclosed deal value, 31 with a post-close Outcome Score for the year 2005.

Median Critic Score: 80  ·  Median Outcome Score: 50

Best outcome: AstraZeneca plc / KuDOS Pharmaceuticals Limited (98)  ·  Weakest outcome: OSI Pharmaceuticals, Inc. / Eyetech Pharmaceuticals, Inc. (10)

All 36 deals

• AstraZeneca plc / KuDOS Pharmaceuticals Limited — 2005 · $210M · Worked — the deal delivered on its rationale.
• Yamanouchi Pharmaceutical Co. / Fujisawa Pharmaceutical Co. — 2005 · Worked — the deal delivered on its rationale.
• Sankyo Co., Ltd. / Daiichi Pharmaceutical Co., Ltd. — 2005 · $8.0B · Worked — the deal delivered on its rationale.
• Cephalon, Inc. / Salmedix, Inc. — 2005 · $160M · Worked — the deal delivered on its rationale.
• Roche Holding AG / GlycArt Biotechnology AG — 2005 · $182M · Worked — the deal delivered on its rationale.
• Reckitt Benckiser plc / Boots Healthcare International — 2005 · $3.4B · Worked — the deal delivered on its rationale.
• Cephalon, Inc. / Cell Therapeutics, Inc. — 2005 · $70M · Largely worked — most objectives met.
• Shire Pharmaceuticals Group plc / Transkaryotic Therapies, Inc. (TKT) — 2005 · $1.6B · Largely worked — most objectives met.
• Solvay S.A. / Fournier Pharma — 2005 · $1.7B · Largely worked — most objectives met.
• GlaxoSmithKline plc / ID Biomedical Corporation — 2005 · $1.4B · Largely worked — most objectives met.
• Cephalon, Inc. / Zeneus Holdings Limited (Zeneus Pharma) — 2005 · $360M · Largely worked — most objectives met.
• Teva Pharmaceutical Industries Ltd. / Ivax Corporation — 2005 · $7.4B · Largely worked — most objectives met.
• Genzyme Corporation / Bone Care International, Inc. — 2005 · $600M · Largely worked — most objectives met.
• Procter & Gamble Company / Gillette Company — 2005 · $57.0B · Mixed — partial payoff, real shortfalls.
• Vertex Pharmaceuticals Inc. / Exonics Therapeutics — 2005 · $1.0B · Mixed — partial payoff, real shortfalls.
• Allergan, Inc. / Inamed Corporation — 2005 · $3.2B · Mixed — partial payoff, real shortfalls.
• Novartis AG / Hexal AG and Eon Labs Inc. — 2005 · $8.4B · Mixed — partial payoff, real shortfalls.
• Inverness Medical Innovations, Inc. / Innogenetics Diagnostica y Terapeutica S.A. (IDT) — 2005 · $19M · Mixed — partial payoff, real shortfalls.
• Pfizer Inc. / Bioren, Inc. — 2005 · Underwhelmed — fell short of the thesis.
• Valeant Pharmaceuticals International / Xcel Pharmaceuticals, Inc. — 2005 · $280M · Underwhelmed — fell short of the thesis.
• Johnson & Johnson / TransForm Pharmaceuticals, Inc. — 2005 · $230M · Underwhelmed — fell short of the thesis.
• Mylan Laboratories Inc. / Matrix Laboratories Limited — 2005 · $736M · Underwhelmed — fell short of the thesis.
• Novartis AG / Chiron Corporation — 2005 · $5.1B · Underwhelmed — fell short of the thesis.
• Inverness Medical Innovations, Inc. / Thermo BioStar, Inc. — 2005 · $52M · Underwhelmed — fell short of the thesis.
• Schering-Plough Corporation / NeoGenesis Pharmaceuticals — 2005 · Underwhelmed — fell short of the thesis.
• Genzyme Corporation / Verigen AG — 2005 · $50M · Did not work — the deal failed to deliver.
• Nektar Therapeutics / Aerogen, Inc. — 2005 · $32M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Vicuron Pharmaceuticals, Inc. — 2005 · $1.9B · Did not work — the deal failed to deliver.
• Johnson & Johnson / Animas Corporation — 2005 · $518M · Did not work — the deal failed to deliver.
• OSI Pharmaceuticals, Inc. / Eyetech Pharmaceuticals, Inc. — 2005 · $935M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Idun Pharmaceuticals, Inc. — 2005 · $298M · Did not work — the deal failed to deliver.
• Sanofi-Aventis Group / ImmunoGen, Inc. — 2005 · $18M
• Indevus Pharmaceuticals, Inc. / Schering AG — 2005 · $30M
• Wyeth Pharmaceuticals / Progenics Pharmaceuticals, Inc. — 2005 · $416M
• Beckman Coulter, Inc. / Diagnostic Systems Laboratories Corporation (DSL) — 2005 · $138M
• Wyeth Pharmaceuticals / Zealand Pharma A/S — 2005

← Deal Library  ·  Interactive search  ·  How we score deals